Risperidone Clinical Trials

• A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
  Schizophrenia
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients
  ClinicalTrials.gov Identifier: NCT00097032 - Active, not recruiting
  Bipolar Disorder
  
• Infusion Laboratory: Protocol 3 (Risperidone) - 4
  ClinicalTrials.gov Identifier: NCT00000339 - Active, not recruiting
  Cocaine-Related Disorders
  
• A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Patients With a History of Being Poorly Compliant With Taking Their Medication
  ClinicalTrials.gov Identifier: NCT00256997 - Recruiting
  Schizophrenia
  
• Risperidone Treatment for Post-Traumatic Stress Disorder (PTSD)
  ClinicalTrials.gov Identifier: NCT00099983 - Recruiting
  PTSD
  
• Study Comparing Adjunctive Risperidone versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00095134 - Active, not recruiting
  Major Depressive Disorder
  
• Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
  ClinicalTrials.gov Identifier: NCT00056498 - Recruiting
  Schizophrenia
  
• A Double-Blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00140426 - Recruiting
  Anorexia Nervosa
  
• CSP #555 Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00132314 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Glucose regulation during risperidone and olanzapine treatment
  ClinicalTrials.gov Identifier: NCT00006195 - Recruiting
  Schizophrenia
  
• Long-Acting Injectable Risperidone in Post-Acute Schizophrenia
  ClinicalTrials.gov Identifier: NCT00216671 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• Risperidone Long-Acting Vs. Oral Risperidone in Patients with Schizophrenia and Alcohol Use Disorder.
  ClinicalTrials.gov Identifier: NCT00130923 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Alcohol Abuse
  
• Evaluation of Efficacy and Safety of Long-Acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
  ClinicalTrials.gov Identifier: NCT00563017 - Recruiting
  Schizophrenia, Catatonic; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenia; Psychotic Disorders
  
• Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial
  ClinicalTrials.gov Identifier: NCT00133822 - Active, not recruiting
  Post-Traumatic Stress Disorder
  
• High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable
  ClinicalTrials.gov Identifier: NCT00539071 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
  ClinicalTrials.gov Identifier: NCT00224315 - Active, not recruiting
  Schizophrenia, Schizoaffective Disorder
  
• Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant
  ClinicalTrials.gov Identifier: NCT00174577 - Active, not recruiting
  Major Depression
  
• A Study of Treatment Success in Changing From Olanzapine to Long-Acting Injectable Risperidone (RISPERDAL® CONSTA™)
  ClinicalTrials.gov Identifier: NCT00216632 - Active, not recruiting
  Psychotic Disorders; Schizophrenia
  
• Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
  ClinicalTrials.gov Identifier: NCT00369239 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder; Psychotic Disorders
  
• Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva
  ClinicalTrials.gov Identifier: NCT00395499 - Completed
  Patients Already Taking Risperidone for Clinical Indications
  
• New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia
  ClinicalTrials.gov Identifier: NCT00161018 - Active, not recruiting
  Schizophrenia
  
• Risperidone Vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
  ClinicalTrials.gov Identifier: NCT00179244 - Active, not recruiting
  Unipolar Depression
  
• A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
  ClinicalTrials.gov Identifier: NCT00216528 - Active, not recruiting
  Schizophrenia
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00246285 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
  ClinicalTrials.gov Identifier: NCT00294008 - Active, not recruiting
  Schizophrenia
  
• Janssen Asperger's MRS Risperidone Study
  ClinicalTrials.gov Identifier: NCT00352196 - Active, not recruiting
  Asperger's Disorder
  
• Study on the Safety and Effectiveness of Risperidone Treatment to Acute Psychotic Patients
  ClinicalTrials.gov Identifier: NCT00515489 - Active, not recruiting
  Schizophreniform Disorder; Schizophrenia; Schizoaffective Disorder
  
• An Open-Label Randomized Trial Comparing Long-Acting Injectable Risperidone With Oral Antipsychotic Medication in the Treatment of Early Psychosis
  ClinicalTrials.gov Identifier: NCT00246259 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• A Study of the Efficacy, Safety, and Quality of Life of Patients With Schizophrenia Receiving Treatment With a Long-Acting Injectable Formulation of Risperidone
  ClinicalTrials.gov Identifier: NCT00269919 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Sertindole Versus Risperidone Safety Outcome Study: A Randomised, Partially-Blinded, Parallel-Group, Active-Controlled, Post-Marketing Study
  ClinicalTrials.gov Identifier: NCT00563550 - Active, not recruiting
  Schizophrenia
  
• A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
  ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• Risperidone LA Study
  ClinicalTrials.gov Identifier: NCT00272597 - Recruiting
  Psychosis, Schizophrenia
  
• Risperidone and Suicidality in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00167154 - Recruiting
  Depression
  
• Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00511628 - Active, not recruiting
  Schizophreniform Disorder; Schizoaffective Disorder; Schizophrenia
  
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00287742 - Active, not recruiting
  Alzheimer's Disease; Dementia
  
• Treatment of Autism in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00005014 - Active, not recruiting
  Autistic Disorder
  
• A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
  ClinicalTrials.gov Identifier: NCT00284206 - Active, not recruiting
  Methamphetamine Dependence
  
• Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00320671 - Recruiting
  Schizophrenia
  
• Maintenance Treatment Vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159120 - Active, not recruiting
  Schizophrenia; Psychoses
  
• Zotepine Versus Risperidone in Aggressive Schizophrenic Patients in an Acute Ward
  ClinicalTrials.gov Identifier: NCT00418873 - Recruiting
  Schizophrenia
  
• Prodrome-Based Early Intervention with Antipsychotics Vs. Benzodiazepines in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159133 - Active, not recruiting
  Schizophrenia; Psychoses
  
• A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249223 - Completed
  Schizophrenia; Psychotic Disorders
  
• One Year Drug Treatment in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
  Schizophrenia
  
• Treatment and Outcome of Early Onset Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00048802 - Active, not recruiting
  Bipolar Disorder
  
• Open label trial exploring a switch from oral medications, to risperidone depot microspheres
  ClinicalTrials.gov Identifier: NCT00034775 - Completed
  Schizophrenia
  
• Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00204347 - Active, not recruiting
  Borderline Personality Disorder
  
• Optimization of Acute Treatment in First Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00157378 - Active, not recruiting
  Schizophrenia, first-episode
  
• Treating Behavioral Disturbances in Individuals with Dementia
  ClinicalTrials.gov Identifier: NCT00073658 - Active, not recruiting
  Dementia; Alzheimer Disease
  
• Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
  ClinicalTrials.gov Identifier: NCT00287820 - Recruiting
  Schizophrenia; Diabetes; Metabolic Syndrome; Hyperglycemia
  
• Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility
  ClinicalTrials.gov Identifier: NCT00308360 - Completed
  Schizophrenia
  
• A Long-Term Safety Study for Long-Acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
  ClinicalTrials.gov Identifier: NCT00495118 - Active, not recruiting
  Schizoaffective Disorder; Schizophrenia
  
• A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
  ClinicalTrials.gov Identifier: NCT00558298 - Active, not recruiting
  Schizoaffective Disorder; Schizophrenia
  
• Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
  ClinicalTrials.gov Identifier: NCT00176202 - Recruiting
  Bipolar Disorder
  
• Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00330551 - Recruiting
  Schizophrenia
  
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Risperidone and Olanzapine.
  ClinicalTrials.gov Identifier: NCT00149955 - Recruiting
  Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Cannabis Abuse
  
• Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone
  ClinicalTrials.gov Identifier: NCT00535132 - Recruiting
  Schizophrenia
  
• Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
  ClinicalTrials.gov Identifier: NCT00221403 - Recruiting
  Bipolar Disorder
  
• Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint
  ClinicalTrials.gov Identifier: NCT00366704 - Recruiting
  Schizophrenia
  
• Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00435370 - Recruiting
  Smoking Cessation; Schizophrenia
  
• A comparison of Seroquel vs. Risperidone in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034905 - Completed
  Schizophrenia
  
• The Efficacy and Safety of Risperidone in the Treatment of Adolescents with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034749 - Completed
  Schizophrenia
  
• Effectiveness of Psychosocial Therapy Plus Risperidone Treatment in Improving Work or School Performance in People With Recent-Onset Schizophrenia
  ClinicalTrials.gov Identifier: NCT00333177 - Recruiting
  Schizophrenia
  
• Investigate Risperidone for the Treatment of Schizophrenia in Adolescents
  ClinicalTrials.gov Identifier: NCT00088075 - Completed
  Schizophrenia
  
• BMI and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine.
  ClinicalTrials.gov Identifier: NCT00312598 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Mood Disorders With Psychotic Features
  
• Switching Medication to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044655 - Recruiting
  Schizophrenia
  
• Study Comparing Adjunctive Risperidone in Generalized Anxiety Disorder that Is Not Responding to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00086112 - Completed
  Anxiety Disorders
  
• Long-Acting Risperidone for First Episode Patients Who Did Not Improve With Their First Antipsychotic Medication
  ClinicalTrials.gov Identifier: NCT00314327 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Psychotic Disorder Not Otherwise Specified
  
• A Study to Evaluate the Effectiveness and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder.
  ClinicalTrials.gov Identifier: NCT00391222 - Recruiting
  Bipolar I Disorder
  
• Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents
  ClinicalTrials.gov Identifier: NCT00573716 - Recruiting
  SSRI Therapy Affects Bone Mineral Content
  
• Schizophrenia Risperidone vs Olanzapine Study HGMN
  ClinicalTrials.gov Identifier: NCT00373321 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
  ClinicalTrials.gov Identifier: NCT00571688 - Recruiting
  Bipolar Disorder
  
• A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
  ClinicalTrials.gov Identifier: NCT00457106 - Recruiting
  Major Depression With Panic Attacks; Panic Disorder
  
• Risperidone Treatment in Dually-Diagnosed Individuals - 2
  ClinicalTrials.gov Identifier: NCT00000267 - Completed
  Cocaine-Related Disorders
  
• Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
  ClinicalTrials.gov Identifier: NCT00480844 - Not yet recruiting
  Schizophrenia
  
• Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00076115 - Completed
  Bipolar Disorder
  
• Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00389493 - Recruiting
  Obsessive-Compulsive Disorder
  
• Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00034762 - Completed
  Dementia, Alzheimer Type
  
• A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
  ClinicalTrials.gov Identifier: NCT00227123 - Recruiting
  Bipolar Disorder; Cocaine Dependence; Amphetamine Dependence
  
• Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
  ClinicalTrials.gov Identifier: NCT00000347 - Completed
  Cocaine-Related Disorders
  
• Early Phase II Trials for Cocaine Medication Development - 1
  ClinicalTrials.gov Identifier: NCT00000317 - Active, not recruiting
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Treatment of Early Age Mania
  ClinicalTrials.gov Identifier: NCT00057681 - Recruiting
  Bipolar Disorder; Manic Disorder
  
• Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
  ClinicalTrials.gov Identifier: NCT00315081 - Not yet recruiting
  Schizophrenia; Hyperprolactinemia
  
• Risperidone Pharmacokinetics in Children with Pervasive Developmental Disorder (PDD)
  ClinicalTrials.gov Identifier: NCT00147394 - Completed
  Child Development Disorders, Pervasive
  
• Risperidone for the Treatment of Cocaine Dependence - 7
  ClinicalTrials.gov Identifier: NCT00000342 - Completed
  Cocaine-Related Disorders
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-Manic Effectiveness of Risperidone Compared With Haloperidol
  ClinicalTrials.gov Identifier: NCT00253162 - Completed
  Manic Disorder; Bipolar Disorders
  
• The Effects on Thinking of Risperidone and Olanzapine
  ClinicalTrials.gov Identifier: NCT00108368 - Completed
  Schizophrenia; Psychotic Disorders
  
• A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
  ClinicalTrials.gov Identifier: NCT00576732 - Not yet recruiting
  Autistic Disorder; Adolescent; Child; Autism
  
• Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00004393 - Completed
  Tourette Syndrome
  
• A Study of the Effectiveness and Safety of Long Acting Risperidone in Patients With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
  ClinicalTrials.gov Identifier: NCT00526877 - Not yet recruiting
  Schizoaffective Disorders; Schizophrenia; Risperdal Consta
  
• Risperidone Augmentation
  ClinicalTrials.gov Identifier: NCT00289861 - Completed
  Schizophrenia
  
• Clozapine and Risperidone for Treatment of First Episode Schizophrenia and Cannabis Use Disorder
  ClinicalTrials.gov Identifier: NCT00063349 - Suspended
  Schizophrenia; Marijuana Abuse
  
• Risperidone Augmentation for PTSD
  ClinicalTrials.gov Identifier: NCT00215241 - Completed
  Post-Traumatic Stress Disorder
  
• Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
  ClinicalTrials.gov Identifier: NCT00361166 - Completed
  Schizophrenia
  
• Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
  ClinicalTrials.gov Identifier: NCT00331825 - Completed
  Schizophrenia; Extrapyramidal Syndrome
  
• Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma
  ClinicalTrials.gov Identifier: NCT00208182 - Completed
  Post-Traumatic Stress Disorder
  
• Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
  ClinicalTrials.gov Identifier: NCT00174200 - Completed
  Schizophrenia; Psychotic Disorders
  
• A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
  ClinicalTrials.gov Identifier: NCT00216580 - Completed
  Schizoaffective Disorder; Schizophreniform Disorders; Schizophrenia
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Injectable Risperidone.
  ClinicalTrials.gov Identifier: NCT00261430 - Completed
  Schizophrenia